
New ACACIA-HCM analyses at HCMS 2026 add imaging and quality-of-life data as Cytokinetics readies an FDA filing in nonobstructive HCM.
Supplements and Featured Publications
This educational resource was sponsored by Johnson & Johnson.
Part 2 of this educational resource provides insights for institutions seeking to implement a pharmacist-led long-acting injectable administration program for schizophrenia.






